Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,461,418
  • Shares Outstanding, K 54,820
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 36-Month Beta 1.21
  • Price/Sales 11.01
  • Price/Cash Flow N/A
  • Price/Book 20.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.40 +16.93%
on 06/18/18
49.89 -10.00%
on 06/22/18
+2.05 (+4.78%)
since 06/13/18
3-Month
38.40 +16.93%
on 06/18/18
59.93 -25.08%
on 04/17/18
-7.36 (-14.08%)
since 04/13/18
52-Week
38.40 +16.93%
on 06/18/18
137.25 -67.29%
on 07/21/17
-84.23 (-65.23%)
since 07/13/17

Most Recent Stories

More News
August 31st Options Now Available For Tesaro (TSRO)

Investors in Tesaro Inc saw new options become available today, for the August 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TSRO options chain for the...

TSRO : 44.90 (+0.13%)
Watch for Tesaro Inc to Potentially Pullback After Gaining 1.38% Yesterday

Tesaro Inc (NASDAQ:TSRO) traded in a range yesterday that spanned from a low of $44.07 to a high of $46.27. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $45.48...

TSRO : 44.90 (+0.13%)
Clovis Gets EU Acceptance for Rubraca Label Expansion Filing

Clovis Oncology's (CLVS) regulatory application seeking label expansion of Rubraca as maintenance treatment was accepted for review in Europe.

AZN : 37.16 (+0.54%)
CLVS : 48.53 (+1.51%)
TSRO : 44.90 (+0.13%)
PFE : 37.53 (+0.03%)
Today's Research Reports on Trending Tickers: Tesaro and REGENXBIO

NEW YORK, NY / ACCESSWIRE / July 4, 2018 / U.S. equities dropped on Tuesday, as gains in energy, real-estate and telecom shares were offset by losses in tech and financial names. The Dow Jones Industrial...

TSRO : 44.90 (+0.13%)
Tesaro Inc Set to Possibly Rebound After Yesterday's Selloff of 8.34%

Tesaro Inc (NASDAQ:TSRO) traded in a range yesterday that spanned from a low of $40.20 to a high of $43.58. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $42.70...

TSRO : 44.90 (+0.13%)
TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute

TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to announce a new partnership supporting the Pan-Mass Challenge (PMC). The PMC is the nation's most successful athletic...

TSRO : 44.90 (+0.13%)
TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing

TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has drawn the $200 million second tranche under its term loan agreement with BIOPHARMA CREDIT PLC and...

TSRO : 44.90 (+0.13%)
TESARO Enters Asset Purchase Agreement with TerSera(R) Therapeutics LLC for VARUBI(R) in the U.S. and Canada

-- TESARO to Receive $40 Million, plus Potential for Additional Milestone Payments and Royalties

TSRO : 44.90 (+0.13%)
AstraZeneca/Merck's Lynparza Betters Survival in Phase III

AstraZeneca (AZN) and Merck's (MRK) Lynparza significantly delays disease progression in a late-stage study evaluating it for the first-line treatment of advanced ovarian cancer.

AZN : 37.16 (+0.54%)
MRK : 62.89 (+0.37%)
CLVS : 48.53 (+1.51%)
TSRO : 44.90 (+0.13%)
Implied Volatility Surging for Tesaro (TSRO) Stock Options

Investors need to pay close attention to Tesaro (TSRO) stock based on the movements in the options market lately.

TSRO : 44.90 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade TSRO with:

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

2nd Resistance Point 46.55
1st Resistance Point 45.72
Last Price 44.90
1st Support Level 44.24
2nd Support Level 43.59

See More

52-Week High 137.25
Fibonacci 61.8% 99.49
Fibonacci 50% 87.82
Fibonacci 38.2% 76.16
Last Price 44.90
52-Week Low 38.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar